Literature DB >> 8613227

Expression of the subtype 1A dopamine receptor in the rat heart.

R Ozono1, D P O'Connell, C Vaughan, S J Botkin, S F Walk, R A Felder, R M Carey.   

Abstract

The subtype 1A dopamine receptor (D1A) has recently been detected in the rat kidney. In the present study using light microscopic immunohistochemistry, electron microscopic immunocytochemistry, and in situ amplification of mRNA, we demonstrate the D1A receptor in Sprague-Dawley and Wistar Kyoto rat hearts. For immunohistochemistry and immunocytochemistry, anti-peptide polyclonal antibodies were directed toward amino acid sequences of the third extracellular and intracellular domains of the native receptor. Selectivity was validated by recognition of the D1A receptor expressed in stably transfected LTK- cells. D1A receptor mRNA was detected with a novel transcription-based isothermal in situ amplification system as well as with reverse transcription-polymerase chain reaction. D1A receptor protein was distributed throughout the atrium and ventricular myocardium. Preimmune and preabsorption controls were negative. Electron microscopic immunocytochemistry using the protein A gold method demonstrated the D1A receptor along the cellular membranes of coronary smooth muscle cells and ventricular myocytes and in the myosin thick filaments and M-lines. D1A receptor mRNA was present in coronary vessels and myocardium in amplified but not in unamplified sections. Western blot analysis showed specific D1A bands in transfected LTK- cells and the atrium but not in nontransfected LTK- cells and the ventricle. The selective D1-like receptor agonist SKF38393 stimulated adenylyl cyclase in ventricular myocardial plasma membranes in a dose-related fashion, and the response was abolished by the selective D1-like receptor antagonist SCH23390. These results demonstrate that the D1A receptor gene and protein are expressed in normal rat heart. The physiological and pathophysiological roles and predominant cell signaling mechanism or mechanisms of this receptor remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613227     DOI: 10.1161/01.hyp.27.3.693

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Dopamine receptor subtypes in the native human heart.

Authors:  Carlo Cavallotti; Massimo Mancone; Paolo Bruzzone; Maurizio Sabbatini; Fiorenzo Mignini
Journal:  Heart Vessels       Date:  2010-09       Impact factor: 2.037

Review 2.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

3.  Expression and distribution of dopamine transporter in cardiac tissues of the guinea pig.

Authors:  Alejandro Reynoso Palomar; Berenice Navarrete Larios; Victoria Chagoya De Sánchez; Lidia Martínez Pérez; Fidel De La Cruz López; Gonzalo Flores; Maria de Jesús Gómez-Villalobos
Journal:  Neurochem Res       Date:  2010-12-19       Impact factor: 3.996

4.  Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension.

Authors:  L D Asico; C Ladines; S Fuchs; D Accili; R M Carey; C Semeraro; F Pocchiari; R A Felder; G M Eisner; P A Jose
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

5.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

6.  Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation.

Authors:  Dong Li; Lena Scott; Susanne Crambert; Sergey Zelenin; Ann-Christine Eklöf; Luis Di Ciano; Fernando Ibarra; Anita Aperia
Journal:  J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 10.121

7.  DR1 Activation Inhibits the Proliferation of Vascular Smooth Muscle Cells through Increasing Endogenous H2S in Diabetes.

Authors:  Yuxin Xi; Xin Wen; Yuanzhou Zhang; Lijie Jiao; Shuzhi Bai; Sa Shi; Guiquan Chang; Ren Wu; Fengqi Sun; Jinghui Hao; Hongzhu Li
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 8.  The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure.

Authors:  Robert M Carey
Journal:  Hypertension       Date:  2013-03       Impact factor: 10.190

9.  Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats.

Authors:  Mohammed Fouad Shalaby; Hekma A Abd El Latif; Mohamed El Yamani; May Ahmed Galal; Sherifa Kamal; Ikhlas Sindi
Journal:  Curr Ther Res Clin Exp       Date:  2021-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.